Notícias
Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.
(Updates with index/price moves, macroeconomic data, and geopolitical news from the first paragraph.
The industrial sector isn't the highest-yielding group on the market, but it's home to some steady payout raisers, including Illinois Tool Works and Waste Management.
XLV offers exposure to the broader healthcare sector, while IBB targets biotech innovators. Here's how the two stack up on risk, returns, and diversification.
While the S&P 500 is up 18.4% since March 2026, Standex (currently trading at $275.55 per share) has lagged behind, posting a return of 6%. This may have investors wondering how to approach the situation.
Sherwin-Williams currently trades at $326.33 per share and has shown little upside over the past six months, posting a middling return of 4%. The stock also fell short of the S&P 500’s 18.4% gain during that period.
Warren Buffett recently penned his last letter to Berkshire Hathaway investors as Chairman.
Over the past six months, Amphastar Pharmaceuticals has been a great trade, beating the S&P 500 by 11.4%. Its stock price has climbed to $24.97, representing a healthy 29.8% increase. This was partly due to its solid quarterly results, and the run-up might have investors contemplating their next move.
Over the past six months, Myriad Genetics’s stock price fell to $4.01. Shareholders have lost 13% of their capital, which is disappointing considering the S&P 500 has climbed by 18.4%. This was partly due to its softer quarterly results and might have investors contemplating their next move.
Cactus has had an impressive run over the past six months as its shares have beaten the S&P 500 by 18.3%. The stock now trades at $66.05, marking a 36.7% gain. This was partly due to its solid quarterly results, and the run-up might have investors contemplating their next move.
Over the past six months, California Resources’s stock price fell to $53.17. Shareholders have lost 18.6% of their capital, which is disappointing considering the S&P 500 has climbed by 18.4%. This was partly due to its softer quarterly results and may have investors wondering how to approach the situation.
Everpure stock advances after the data-storage company says revenue growth will continue to accelerate in fiscal 2028.
Over the past six months, Genesis Energy’s shares (currently trading at $14.67) have posted a disappointing 18.2% loss, well below the S&P 500’s 18.4% gain. This may have investors wondering how to approach the situation.
VanEck's concentrated 25-stock biotech portfolio surged 40.5% in one year, but Fidelity's diversified 365-holding fund delivered superior risk-adjusted returns with half the volatility.
Long-term investors shouldn't fear a bear market.
Stocks were in the red on Thursday, but the losses weren't that severe considering the scale of the bond market weakness. The S&P 500 was down 0.2% to 7693.66, just 1.4% from its record high closing price, according to Dow Jones Market Data. The Nasdaq Composite dropped 0.5%, trading only 1.6% from its respective high.
Tran Capital Management, an investment management company, released its second-quarter investor letter for its “Midcap Equity Strategy”. The letter can be downloaded here. The Midcap Equity Strategy returned 16.9%, net of fees, in the second quarter, bringing year-to-date returns to 12.3%, compared with Bloomberg U.S. Mid Cap Index’s 11.1% quarterly gains and 12.1% year-to-date returns. […]
Procter & Gamble currently trades at $147.39 per share and has shown little upside over the past six months, posting a middling return of 3%. The stock also fell short of the S&P 500’s 18.4% gain during that period.
Tran Capital Management, an investment management company, released its second-quarter investor letter for its “Multi Cap Growth Strategy”. You can download a copy of the letter here. In Q2, the Strategy returned 17.5% net (YTD 10.5%), outperforming the S&P 500 (15.2%) and Bloomberg U.S. Mid Cap Index (11.1%). Patient discipline during Q1’s sell-off drove these […]
Tran Capital Management, an investment management company, released its second-quarter investor letter for its “Multi Cap Growth Strategy”. You can download a copy of the letter here. In Q2, the Strategy returned 17.5% net (YTD 10.5%), outperforming the S&P 500 (15.2%) and Bloomberg U.S. Mid Cap Index (11.1%). Patient discipline during Q1’s sell-off drove these […]
Colgate-Palmolive currently trades at $86.14 per share and has shown little upside over the past six months, posting a middling return of 1.9%. The stock also fell short of the S&P 500’s 18.4% gain during that period.
The next bear market may be your best opportunity to grow your portfolio.
CBRE has been treading water for the past six months, recording a small return of 2.6% while holding steady at $136.36. The stock also fell short of the S&P 500’s 18.4% gain during that period.
Since March 2026, Alight has been in a holding pattern, posting a small loss of 2.1% while floating around $12.58. The stock also fell short of the S&P 500’s 18.4% gain during that period.
Since March 2026, Omnicom Group has been in a holding pattern, floating around $75.49. The stock also fell short of the S&P 500’s 18.4% gain during that period.
Sept 24 (Reuters) - Wall Street's main stock indexes opened lower on Thursday as simmering Middle East tensions lifted oil prices and Treasury yields, while investors also exercised caution ahead of a
The stock market extended losses on Thursday with all three major indexes opening lower as Treasury yields continued to rise. The S&P 500 fell 0.5%. The Nasdaq Composite dropped 0.8%. The Dow Jones Industrial Average was down 0.
Barry Diller just pulled a blockbuster buyout offer for one of Las Vegas's biggest casino operators, and the market is punishing the stock hard while leaving rivals completely unscathed. Find out what his next move signals for MGM shareholders.